PW MEDTECH (01358) spent about HK$400,000 to repurchase 344,000 shares on May 27th.
Puhua and Shun (01358) announced the repurchase of approximately 344,000 shares at a cost of about HKD 400,000 on May 27, 2026.
PW MEDTECH (01358) announced that on May 27, 2026, it has repurchased approximately 344,000 shares for a total cost of approximately HK$400,000.
Related Articles
.png)
JIUMAOJIU (09922) repurchased 427,000 shares for HK$650,800 on May 27th.
QYUNS-B (02509) has just completed the first subject dosed in the Phase I clinical trial of QX031N and received a milestone payment from Roche.
TRANSTHERA-B (02617) has completed the issuance of a total of 3.836 million shares of placement shares.
JIUMAOJIU (09922) repurchased 427,000 shares for HK$650,800 on May 27th.
QYUNS-B (02509) has just completed the first subject dosed in the Phase I clinical trial of QX031N and received a milestone payment from Roche.
TRANSTHERA-B (02617) has completed the issuance of a total of 3.836 million shares of placement shares.
